David McManus to Secondary Prevention
This is a "connection" page, showing publications David McManus has written about Secondary Prevention.
Connection Strength
0.280
-
Tisminetzky M, McManus DD, Gore JM, Yarzebski J, Coles A, Lessard D, Goldberg RJ. 30-year trends in patient characteristics, treatment practices, and long-term outcomes of adults aged 35 to 54?years hospitalized with acute myocardial infarction. Am J Cardiol. 2014 Apr 01; 113(7):1137-41.
Score: 0.100
-
McManus DD, Piacentine SM, Lessard D, Gore JM, Yarzebski J, Spencer FA, Goldberg RJ. Thirty-year (1975 to 2005) trends in the incidence rates, clinical features, treatment practices, and short-term outcomes of patients <55 years of age hospitalized with an initial acute myocardial infarction. Am J Cardiol. 2011 Aug 15; 108(4):477-82.
Score: 0.083
-
Alcusky M, Hume AL, Fisher M, Tjia J, Goldberg RJ, McManus DD, Lapane KL. Dabigatran Versus Rivaroxaban for Secondary Stroke Prevention in Patients with Atrial Fibrillation Rehabilitated in Skilled Nursing Facilities. Drugs Aging. 2018 12; 35(12):1089-1098.
Score: 0.035
-
Betz JK, Katz DF, Peterson PN, Borne RT, Al-Khatib SM, Wang Y, Hansen CM, McManus DD, Mathew JS, Masoudi FA. Outcomes Among Older Patients Receiving Implantable Cardioverter-Defibrillators for Secondary Prevention: From the NCDR ICD Registry. J Am Coll Cardiol. 2017 01 24; 69(3):265-274.
Score: 0.031
-
Makam RC, Erskine N, McManus DD, Lessard D, Gore JM, Yarzebski J, Goldberg RJ. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction. Am J Cardiol. 2016 Dec 15; 118(12):1792-1797.
Score: 0.030